Trending
- Work, Money, & a Normal Life
- AACR in 30 Seconds: Revolution Medicines data, NCI director, wildfires
- HDAC8 inhibition targets STAT3–MYC axis and synergizes with Venetoclax in KMT2A-rearranged acute myeloid leukemia
- Mastectomy, ET Linked to Lower LRR in Young Populations With Breast Cancer
- Revolution Medicines previews ‘novel class’ of cancer treatments
- Outlining Common Drawbacks to Prior Standards for Hodgkin Lymphoma
- CD39/PD-L1 Inhibition May Improve pCR Rate in Resectable NSCLC
- Cilta-Cel Produces Early Responses in Smoldering Multiple Myeloma
Wednesday, April 22